Infections in patients taking Rituximab for hematologic malignancies: two-year cohort study

Rituximab is a chimeric human-murine anti-CD20 monoclonal antibody used to treat B-cell lymphomas.

http://www.biomedcentral.com/1471-2334/13/317/abstract